Should Leukotriene Antagonists Have Higher Priority for Asthma Control?

Kuritzky, Louis
June 2011
Internal Medicine Alert;6/29/2011, Vol. 33 Issue 12, p96
The article reports on the inconsistent findings in comparator trials of using leukotriene inhibitors (LKT) with inhaled corticosteroids (ICS) as the preferred medication for asthma control.


Related Articles

  • Should Leukotriene Antagonists Have Higher Priority for Asthma Control?  // OB/GYN Clinical Alert;Jul2011 Clinical Briefs in Primary, Vol. 16 Issue 7, p14 

    The article presents a research on the role of leukotriene inhibitors (LKT) in inhaled corticosteroids (ICS) for "controller" maintenance medication for persistent asthma.

  • Comparative Efficacy of Inhaled Corticosteroids and Antileukotriene Drugs in Asthma. Smith, L.J. // BioDrugs;2001, Vol. 15 Issue 4, p239 

    Asthma is an inflammatory disease of the airways that is best treated by minimising exposure to factors that provoke the inflammation (e.g. allergens) and by administering drugs that reduce the inflammatory response. The cornerstone of asthma treatment is inhaled corticosteroids. Their...

  • Modern drug treatment of chronic asthma. Lipworth, Brian J // BMJ: British Medical Journal (International Edition);02/06/99, Vol. 318 Issue 7180, p380 

    Provides a brief overview of modern drug treatment for chronic asthma. Corticosteroids; Cromones; Leukotriene antagonists.

  • Comparing leukotriene inhibitors and corticosteroids in asthma. Pinkowish, Mary Desmond // Patient Care;6/15/1999, Vol. 33 Issue 11, p34 

    Compares the efficacy of inhaled corticosteroids and oral leukotriene receptor antagonists as treatments for asthma. Positive and negative aspects of the treatments; Oral agents as easier for patients to use; Understanding of the pathophysiology of asthma; Patients' preference for taking pills...

  • Should LTRAs Be First-Line or Add-On Asthma Therapy? Marshall, Adriene // Pulmonary Reviews;Jun2011, Vol. 16 Issue 6, p20 

    The article discusses a study which suggested that leukotriene-receptor antagonists (LTRA) are equivalent to inhaled glucoccorticoids as first-line controller asthma therapy and to long-acting β-agonists (LABA) as add-on therapy to an inhaled corticosteroid, with reference to a study...

  • Cost-Efficacy Analysis of Fluticasone Propionate versus Zafirlukast in Patients with Persistent Asthma. Menendez, R.; Stanford, R.H.; Edwards, L.; Kalberg, C.; Rickard, K. // PharmacoEconomics;Aug2001, Vol. 19, p865 

    Objective: To compare the relative value of an inhaled corticosteroid, fluticasone propionate 88µg twice daily, versus an oral leukotriene receptor antagonist, zafirlukast 20mg twice daily, in patients with persistent asthma currently receiving short acting β-agonists alone. Study design:...

  • Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma? Jartti, Tuomas // European Journal of Pediatrics;Jul2008, Vol. 167 Issue 7, p731 

    According to current guidelines, inhaled corticosteroids (ICS) are the preferred primary long-term treatment for asthmatic children of all age groups, but leukotriene receptor antagonists can be considered to be an alternative treatment for mild persistent asthma. In this article, all randomized...

  • Pharmacotherapy -- add-on therapies.  // CMAJ: Canadian Medical Association Journal;9/13/2005 Supplement, Vol. 173, pS37 

    The article focuses on the effectiveness regarding the use inhaled corticosteriods (ICS)and leukotriene receptor antagonists (LTRA)as add-on therapy in treating children with asthma. The effectiveness ICS has been compared with long-acting bronchodilators (LABA) such as salmenterol or...

  • Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review. Kankaanranta, Hannu; Lahdensuo, Aarne; Moilanen, Eeva; Barnes, Peter J. // Respiratory Research;2004, Vol. 5, p17 

    Many patients with persistent asthma can be controlled with inhaled corticosteroids (ICS). However, a considerable proportion of patients remain symptomatic, despite the use of ICS. We present systematically evidence that supports the different treatment options. A literature search was made of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics